JP2012523573A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012523573A5 JP2012523573A5 JP2012505086A JP2012505086A JP2012523573A5 JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5 JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012505086 A JP2012505086 A JP 2012505086A JP 2012523573 A5 JP2012523573 A5 JP 2012523573A5
- Authority
- JP
- Japan
- Prior art keywords
- diagnostic method
- disease
- antibiotics
- administration
- induced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002405 diagnostic procedure Methods 0.000 claims 10
- 239000003242 anti bacterial agent Substances 0.000 claims 8
- 229940088710 antibiotic agent Drugs 0.000 claims 8
- 239000012634 fragment Substances 0.000 claims 8
- 208000031662 Noncommunicable disease Diseases 0.000 claims 5
- 108010048233 Procalcitonin Proteins 0.000 claims 5
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 claims 5
- 238000004393 prognosis Methods 0.000 claims 5
- 239000002243 precursor Substances 0.000 claims 4
- 230000002411 adverse Effects 0.000 claims 3
- 208000037920 primary disease Diseases 0.000 claims 3
- 238000013517 stratification Methods 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010007556 Cardiac failure acute Diseases 0.000 claims 1
- 206010007558 Cardiac failure chronic Diseases 0.000 claims 1
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000015114 central nervous system disease Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09157886 | 2009-04-14 | ||
| EP09157886.4 | 2009-04-14 | ||
| PCT/EP2010/002279 WO2010118855A1 (en) | 2009-04-14 | 2010-04-14 | Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012523573A JP2012523573A (ja) | 2012-10-04 |
| JP2012523573A5 true JP2012523573A5 (cg-RX-API-DMAC10.html) | 2012-11-15 |
| JP5650718B2 JP5650718B2 (ja) | 2015-01-07 |
Family
ID=40886944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012505086A Active JP5650718B2 (ja) | 2009-04-14 | 2010-04-14 | プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 |
Country Status (15)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN2014MN02101A (cg-RX-API-DMAC10.html) | 2012-04-12 | 2015-08-28 | Brahms Gmbh | |
| CN105528511A (zh) * | 2014-10-25 | 2016-04-27 | 潘一琦 | 一种远程诊疗对比式问诊方法及其系统 |
| CN107301319B (zh) * | 2017-06-26 | 2021-02-26 | 济南市儿童医院 | 儿科临床及科研中抗菌药物使用危险评估系统 |
| EP3502706A1 (en) * | 2017-12-20 | 2019-06-26 | B.R.A.H.M.S GmbH | Workflow for risk assessment and patient management using procalcitonin and midregional-proadrenomedullin |
| WO2019122088A1 (en) * | 2017-12-20 | 2019-06-27 | B.R.A.H.M.S Gmbh | Antibiotic therapy guidance based on procalcitonin in patients with comorbidities |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314804A (en) * | 1992-03-24 | 1994-05-24 | Serim Research Corporation | Test for Helicobacter pylori |
| DE19600875C1 (de) * | 1996-01-12 | 1997-06-26 | Brahms Diagnostica Gmbh | Diagnostisches Verfahren zur Bestimmung der Ätiologie entzündlicher Prozesse |
| EP1110970B1 (de) * | 1999-12-22 | 2008-05-14 | Dade Behring Marburg GmbH | Gegen Procalcitonin gerichtete Antikörper, ihre Herstellung und Verwendung |
| DE60233949D1 (de) * | 2001-08-20 | 2009-11-19 | Biosite Inc | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon |
| US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| DE102005034174A1 (de) * | 2005-07-21 | 2007-02-08 | B.R.A.H.M.S Ag | Liquordiagnostisches in vitro Verfahren zur Diagnose von Demenz-Erkrankungen und neuroinflammatorischen Erkrankungen |
| FR2894675B1 (fr) * | 2005-12-14 | 2008-06-27 | Assist Publ Hopitaux De Paris | Distinction des meningites bacteriennes et virales |
| DE102006046996A1 (de) | 2006-10-01 | 2008-04-03 | Brahms Aktiengesellschaft | Diagnose von Infektionen oder Entzündungserkrankungen der Atemwege und Lunge assoziiert mit Herzinsuffizienz |
| ATE533061T1 (de) | 2007-08-03 | 2011-11-15 | Brahms Gmbh | Verfahren zur diagnose bakterieller infektionen |
-
2010
- 2010-04-14 HU HUE10717531A patent/HUE046182T2/hu unknown
- 2010-04-14 SI SI201031945T patent/SI2419741T1/sl unknown
- 2010-04-14 PL PL10717531T patent/PL2419741T3/pl unknown
- 2010-04-14 LT LT10717531T patent/LT2419741T/lt unknown
- 2010-04-14 DK DK10717531T patent/DK2419741T3/da active
- 2010-04-14 JP JP2012505086A patent/JP5650718B2/ja active Active
- 2010-04-14 EP EP10717531.7A patent/EP2419741B1/en not_active Revoked
- 2010-04-14 WO PCT/EP2010/002279 patent/WO2010118855A1/en not_active Ceased
- 2010-04-14 CN CN201510626744.9A patent/CN105334330A/zh active Pending
- 2010-04-14 PT PT107175317T patent/PT2419741T/pt unknown
- 2010-04-14 US US13/264,252 patent/US9046532B2/en active Active
- 2010-04-14 CN CN201080016849.8A patent/CN102395888B/zh active Active
- 2010-04-14 ES ES10717531T patent/ES2751105T3/es active Active
- 2010-04-14 HR HRP20191862TT patent/HRP20191862T1/hr unknown
-
2015
- 2015-03-30 US US14/672,801 patent/US9810699B2/en active Active
-
2016
- 2016-08-16 HK HK16109795.0A patent/HK1221766A1/zh unknown
-
2017
- 2017-11-06 US US15/804,282 patent/US20180052179A1/en not_active Abandoned
-
2019
- 2019-10-24 CY CY20191101107T patent/CY1122202T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Behr | The diagnosis and treatment of idiopathic pulmonary fibrosis | |
| Jeschke et al. | Morbidity and survival probability in burn patients in modern burn care | |
| Fan et al. | Sex‐specific association between serum uric acid and nonalcoholic fatty liver disease in type 2 diabetic patients | |
| Corhay et al. | Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross‐sectional multicentre study | |
| EP4184167A1 (en) | Early diagnosis of infections | |
| Shi et al. | Tumour biomarkers: association with heart failure outcomes | |
| JP7277465B2 (ja) | プロカルシトニンと中間領域プロアドレノメデュリンを使用したリスク評価と患者管理のためのワークフロー | |
| Brussino et al. | Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer | |
| Boeckmans et al. | Liver stiffness as a cornerstone in heart disease risk assessment | |
| Pan et al. | Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis. | |
| JP2007514651A5 (cg-RX-API-DMAC10.html) | ||
| Schiavetti et al. | Long‐term renal function in unilateral non‐syndromic renal tumor survivors treated according to International Society of Pediatric Oncology protocols | |
| Langsford et al. | The association between biomarker profiles, etiology of chronic kidney disease, and mortality | |
| Singh et al. | Idiopathic pulmonary fibrosis: where do we stand and how far to go | |
| JP2024009019A (ja) | 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス | |
| Wan et al. | Postinfectious bronchiolitis obliterans in children | |
| Hao et al. | Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study | |
| JP2017519008A5 (cg-RX-API-DMAC10.html) | ||
| JP5650718B2 (ja) | プロカルシトニンのレベルを測定することによる原発性非感染症疾患に罹患している患者における抗生物質処置のためのリスク評価 | |
| EP3682241B1 (en) | Pct and pro-adm as markers for monitoring antibiotic treatment | |
| Ibrahim et al. | COVID-19 and Liver Dysfunction | |
| Sy‐Janairo et al. | Association of metabolic‐associated fatty liver disease and risk of severe coronavirus disease 2019 illness | |
| Park et al. | Korean guidelines for diagnosis and management of interstitial lung diseases | |
| Jiang et al. | Self-reported snoring is associated with chronic kidney disease in obese but not in normal-weight Chinese adults | |
| Shrestha et al. | A study on the lipid ratios and inflammatory markers in pre-diabetic and diabetic patients |